Patents : |  |
| US Patent No. | Title |
| 7348149 | Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1
|
| 7419996 | Parenteral and oral formulations of benzimidazoles
|
| 7429646 | Antibodies to human tumor necrosis factor receptor-like 2
|
| 7435808 | Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
|
| 7439333 | Vascular endothelial growth factor 2
|
| 7442532 | Essential fungal CaYLR100w polypeptides, and methods of use
|
| 7446176 | 12 human secreted proteins
|
| 7456256 | BGS 4
|
| 7459531 | 50 Human secreted proteins
|
| 7459532 | Variants of the TRP channel family member, LTRPC3G
|
| 7465568 | Essential fungal polynucleotides, polypeptides, and methods of use
|
| 7417121 | Human G-protein coupled receptor, HGPRBMY39
|
| 7411051 | Antibodies to HDPPA04 polypeptide
|
| 7407988 | Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
|
| 7358074 | Human phosphatase RET31, and variants thereof
|
| 7368527 | HADDE71 polypeptides
|
| 7368531 | Human secreted proteins
|
| 7371388 | Treatment of Sjogren's syndrome by administration of TR18 polypeptides
|
| 7371822 | Human G-protein coupled receptor variant of HM74, HGPRBMY74
|
| 7381800 | Antibodies to HBIMF63 polypeptide
|
| 7390637 | Keratinocyte derived interferon
|
| 7393934 | Human G-protein chemokine receptor (CCR5) HDGNR10
|
| 7396819 | Anthelmintic formulations
|
| 7396820 | Anthelmintic formulations
|
| 7465707 | Methods of treatment with TR10 polypeptides
|
| 7465719 | Carbamic acid compounds comprising an ester or ketone linkage as HDAC inhibitors
|
| 7531186 | Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz
|
| 7534455 | Herbal composition PHY906 and its use in chemotherapy
|
| 7541434 | Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants
|
| 7557140 | Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
|
| 7569384 | Albumin fusion proteins
|
| 7569724 | Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
|
| 7572618 | Polynucleotides encoding novel PCSK9 variants
|
| 7582612 | Multi-action anthelmintic formulations
|
| 7592010 | Albumin fusion proteins
|
| 7595038 | Methods of treatment using antibodies to follistatin-3
|
| 7521424 | Albumin fusion proteins
|
| 7517440 | Electrokinetic delivery systems, devices and methods
|
| 7514217 | Markers for alternatively activated macrophages
|
| 7470773 | Immunoglobulin E detection in mammalian species
|
| 7482013 | Albumin fusion proteins
|
| 7482442 | HEMCM42 nucleic acids
|
| 7494992 | Antiparasitic terpene alkaloids
|
| 7498027 | Methods of treatment using human tumor necrosis factor receptor TR17 antibodies
|
| 7501123 | Human G-protein chemokine receptor (CCR5) HDGNR10
|
| 7504105 | Treatment using antibodies to cytokine receptor common gamma chain like
|
| 7504481 | TRP channel family member, LTRPC3 polypeptides
|
| 7507413 | Albumin fusion proteins
|
| 7507414 | Albumin fusion proteins
|
| 7598348 | Adiponectin receptor variant, AdipoR2v2
|
